BioReliance
 
Home About Us Services What's Your Product? Resources Careers Contact Us
  Home
 

News

Darryl L. Goss joins Bioreliance Darryl L. Goss has been appointed Vice President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly formed Business Unit.
Click here to read the press release.

 

   

Many of the world's leading biologics are based on cell banks produced and safety-tested by BioReliance. Trust us to take care of yours.

What is Cell Line Characterization?

Cell Line Characterization is a series of tests intended to confirm the identity and purity of the cell substrate. The testing must also verify the absence of cross-contamination and determine if the cells are prone to genetic instability.


The Regulatory View

All regulatory requirements for cell line characterization have three major components:

  • Source history and generation of the cell substrate
  • Characterization and testing to establish identity, purity and stability
  • Cell Banking procedures

To ensure the quality and integrity of data derived from cell bank characterization and testing, laboratory studies designed for characterization of banked cells must comply with current good manufacturing practice (GLP) regulations for nonclinical studies including the U.S. Food and Drug Administration’s Good Laboratory Practice Regulation, the United Kingdom’s Good Laboratory Practice, and Japan’s Good Laboratory Practice Standard. If the product is to be marketed internationally, then initial efforts should be placed on developing cell line characterization and testing programs that satisfy regulatory requirements and recommendations of the U.S. Food and Drug Administration (FDA), the European Medicines Evaluation Agency (EMEA), and the Japanese Ministry of Health and Welfare. This foresight will alleviate the need for repeated and/or additional testing at the time of product license application submission. BioReliances’ Regulatory Affairs section can offer advice and assistance with regulatory issues.

Cell Line Characterization at BioReliance

BioReliance has established and characterized over 300 client cell banks, and offer a complete testing program covering identity and homogeneity, purity and suitability for use. Programs are custom designed to take into account the species of origin and culture history of the cells.

Tests include:

  • Sterility and mycoplasma testing
  • Isoenzyme analysis
  • In vitro and in vivo assays for adventitious viral contaminants
  • PCR and Q-PCR assays
  • Retroviral infectivity assays, and more

Our scientists are experts in cGMP, cell bank production and characterization. Additionally a single point-of-contact is assigned to your program, keeping things simple, focussed and accessible at all times.

IIf you would like more detailed information, or have a specific query, please contact us at info@bioreliance.com or complete the form below.

Cell Line Characterization query form:

Name:

Organization:
Title:
Address:
Country:
Phone (optional)
Email:

What is your query?

The following section is entirely optional, but will help us target our service:
When are you planning cell line characterization?

 

May we contact you to offer input into the design of your cell line characterization studies?
Which cell lines are you using?

CHO
PER.C6
Vero

Other (please specify)

The following cell line characterization publications are produced by BioReliance. Please tick to request a free copy. (Be sure to include your full posting address) .

"Cell Line Authentication Using Isoenzyme Analysis" (BioPharm International, June 2005)
"Characterization of endogenous retrovirus in rodent cell line used for production of Biologics"
Cell Line Characterization (22 page guide)
Cell Bank Development and Characterization (flyer)
Cell Storage Services (flyer)

 

 

Have you laid down a
cGMP cell bank yet?

Let BioReliance help.
Find out more

 

 

 

 

 
 
 
 
 
 
 
 
 
 
for further information and enquiries please contact: info@bioreliance.com